Advertisement
Special Article|Articles in Press

Arrhythmic Mitral Valve Prolapse (AMVP): Risk Assessment and Management

      Abstract

      Arrhythmic mitral valve prolapse (AMVP) has gained great interest recently given the increasing recognition of its potential role in unexplained cardiac arrest. While evidence has accumulated to demonstrate the association between AMVP with sudden cardiac death (SCD), risk stratification and management remain unclear. Physicians are faced with the challenges of screening for AMVP among MVP patients and the dilemma of when and how to intervene to prevent SCD in these patients. In addition, there is little guidance to help approach MVP patients presenting with an otherwise unexplained cardiac arrest to know whether MVP was the primary cause of cardiac arrest or just an innocent bystander. Herein we review the epidemiology and definition of AMVP, the risk and mechanisms of SCD, and summarize the clinical evidence behind risk markers of SCD and therapeutic interventions that could potentially prevent it. Lastly, we propose an algorithm that provides guidance as to how to screen for AMVP and what therapeutic interventions to use. Also, we propose a diagnostic algorithm for approaching patients with otherwise unexplained cardiac arrest who are found to have MVP.
      Mitral valve prolapse (MVP) is a common condition (1-3%) which is typically asymptomatic. However, individuals with MVP are at risk of chordal rupture, progressive mitral regurgitation, endocarditis, ventricular arrhythmias and rarely, sudden cardiac death (SCD). There is evidence from autopsy series and cohorts of survivors of unexplained cardiac arrest that MVP is more prevalent in these populations, suggesting that it may have a causal role in cardiac arrest in susceptible individuals. Potential mechanisms include scar-related re-entry due to scarring of papillary muscles or impact lesions in the left ventricle due to the collision between redundant mitral leaflets and the left ventricle.
      Recently, risk markers have been identified that help predict the small proportion of patients with MVP who are at risk of SCD. Patients with MVP who have several of these risk markers or who have survived an otherwise unexplained cardiac arrest are said to have Arrhythmogenic Mitral Valve Prolapse (AMVP).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References:

        • Levine R.A.
        • Stathogiannis E.
        • Newell J.B.
        • Harrigan P.
        • Weyman A.E.
        Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality.
        J Am Coll Cardiol. 1988; 11: 1010-1019
        • Freed L.A.
        • Levy D.
        • Levine R.A.
        • et al.
        Prevalence and clinical outcome of mitral-valve prolapse.
        N Engl J Med. 1999; 341: 1-7
        • Delling F.N.
        • Rong J.
        • Larson M.G.
        • et al.
        Familial clustering of mitral valve prolapse in the community.
        Circulation. 2015; 131: 263-268
        • Theal M.
        • Sleik K.
        • Anand S.
        • Yi Q.
        • Yusuf S.
        • Lonn E.
        Prevalence of mitral valve prolapse in ethnic groups.
        Can J Cardiol. 2004; 20: 511-515
        • Nishimura R.A.
        • McGoon M.D.
        • Shub C.
        • Miller Jr., F.A.
        • Ilstrup D.M.
        • Tajik A.J.
        Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients.
        N Engl J Med. 1985; 313: 1305-1309
        • Duren D.R.
        • Becker A.E.
        • Dunning A.J.
        Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study.
        J Am Coll Cardiol. 1988; 11: 42-47
        • Zuppiroli A.
        • Rinaldi M.
        • Kramer-Fox R.
        • Favilli S.
        • Roman M.J.
        • Devereux R.B.
        Natural history of mitral valve prolapse.
        Am J Cardiol. 1995; 75: 1028-1032
        • Avierinos J.F.
        • Gersh B.J.
        • Melton 3rd, L.J.
        • et al.
        Natural history of asymptomatic mitral valve prolapse in the community.
        Circulation. 2002; 106: 1355-1361
      1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72-e227.

        • Han H.C.
        • Ha F.J.
        • Teh A.W.
        • et al.
        Mitral Valve Prolapse and Sudden Cardiac Death: A Systematic Review.
        J Am Heart Assoc. 2018; 7e010584
        • Alqarawi W.
        • Cheung C.C.
        • Davies B.
        • Krahn A.D.
        Arrhythmic Mitral Valve Prolapse: Looking for a Needle in a Haystack.
        J Am Coll Cardiol. 2020; 76: 2688-2689
      2. Sabbag A, Essayagh B, Barrera JDR, et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2022;24:1981-2003.

        • Essayagh B.
        • Sabbag A.
        • Antoine C.
        • et al.
        Presentation and Outcome of Arrhythmic Mitral Valve Prolapse.
        J Am Coll Cardiol. 2020; 76: 637-649
        • Basso C.
        • Perazzolo Marra M.
        • Rizzo S.
        • et al.
        Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death.
        Circulation. 2015; 132: 556-566
        • Nalliah C.J.
        • Mahajan R.
        • Elliott A.D.
        • et al.
        Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis.
        Heart. 2019; 105: 144-151
        • Sriram C.S.
        • Syed F.F.
        • Ferguson M.E.
        • et al.
        Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest.
        J Am Coll Cardiol. 2013; 62: 222-230
      3. AMVP in CASPER.

        • Groeneveld S.A.
        • Kirkels F.P.
        • Cramer M.J.
        • et al.
        Prevalence of Mitral Annulus Disjunction and Mitral Valve Prolapse in Patients With Idiopathic Ventricular Fibrillation.
        J Am Heart Assoc. 2022; 11e025364
        • Davies B.
        • Roberts J.D.
        • Tadros R.
        • et al.
        The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network.
        CJC Open. 2020; 2: 652-662
        • Grigioni F.
        • Enriquez-Sarano M.
        • Ling L.H.
        • et al.
        Sudden death in mitral regurgitation due to flail leaflet.
        J Am Coll Cardiol. 1999; 34: 2078-2085
        • Constant Dit Beaufils A.L.
        • Huttin O.
        • Jobbe-Duval A.
        • et al.
        Replacement Myocardial Fibrosis in Patients With Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling, and Arrhythmia.
        Circulation. 2021; 143: 1763-1774
        • Boudoulas H.
        • Kolibash Jr., A.J.
        • Baker P.
        • King B.D.
        • Wooley C.F.
        Mitral valve prolapse and the mitral valve prolapse syndrome: a diagnostic classification and pathogenesis of symptoms.
        Am Heart J. 1989; 118: 796-818
        • Vohra J.
        • Sathe S.
        • Warren R.
        • Tatoulis J.
        • Hunt D.
        Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation.
        Pacing Clin Electrophysiol. 1993; 16: 387-393
        • Mason J.W.
        • Koch F.H.
        • Billingham M.E.
        • Winkle R.A.
        Cardiac biopsy evidence for a cardiomyopathy associated with symptomatic mitral valve prolapse.
        Am J Cardiol. 1978; 42: 557-562
        • Turker Y.
        • Ozaydin M.
        • Acar G.
        • et al.
        Predictors of ventricular arrhythmias in patients with mitral valve prolapse.
        Int J Cardiovasc Imaging. 2010; 26: 139-145
        • Savage D.D.
        • Devereux R.B.
        • Garrison R.J.
        • et al.
        Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study.
        Am Heart J. 1983; 106: 577-581
        • Hourdain J.
        • Clavel M.A.
        • Deharo J.C.
        • et al.
        Common Phenotype in Patients With Mitral Valve Prolapse Who Experienced Sudden Cardiac Death.
        Circulation. 2018; 138: 1067-1069
        • Roselli C.
        • Yu M.
        • Nauffal V.
        • et al.
        Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.
        European heart journal. 2022; 43: 1668-1680
        • Giudicessi J.R.
        • Maleszewski J.J.
        • Tester D.J.
        • Ackerman M.J.
        Prevalence and potential genetic determinants of young sudden unexplained death victims with suspected arrhythmogenic mitral valve prolapse syndrome.
        Heart Rhythm O2. 2021; 2: 431-438
        • Humphries J.
        • McKusick V.
        The differentiation of organic and "innocent" systolic murmurs.
        Prog Cardiovasc Dis. 1962; 5: 152-171
        • Bhutto Z.R.
        • Barron J.T.
        • Liebson P.R.
        • Uretz E.F.
        • Parrillo J.E.
        Electrocardiographic abnormalities in mitral valve prolapse.
        Am J Cardiol. 1992; 70: 265-266
        • Marano P.J.
        • Lim L.J.
        • Sanchez J.M.
        • et al.
        Long-term outcomes of ablation for ventricular arrhythmias in mitral valve prolapse.
        J Interv Card Electrophysiol. 2021; 61: 145-154
        • Good E.
        • Desjardins B.
        • Jongnarangsin K.
        • et al.
        Ventricular arrhythmias originating from a papillary muscle in patients without prior infarction: a comparison with fascicular arrhythmias.
        Heart rhythm : the official journal of the Heart Rhythm Society. 2008; 5: 1530-1537
        • Enriquez A.
        • Supple G.E.
        • Marchlinski F.E.
        • Garcia F.C.
        How to map and ablate papillary muscle ventricular arrhythmias.
        Heart rhythm : the official journal of the Heart Rhythm Society. 2017; 14: 1721-1728
        • Hutchins G.M.
        • Moore G.W.
        • Skoog D.K.
        The association of floppy mitral valve with disjunction of the mitral annulus fibrosus.
        N Engl J Med. 1986; 314: 535-540
        • Faletra F.F.
        • Leo L.A.
        • Paiocchi V.L.
        • et al.
        Morphology of Mitral Annular Disjunction in Mitral Valve Prolapse.
        J Am Soc Echocardiogr. 2022; 35: 176-186
        • Dejgaard L.A.
        • Skjolsvik E.T.
        • Lie O.H.
        • et al.
        The Mitral Annulus Disjunction Arrhythmic Syndrome.
        J Am Coll Cardiol. 2018; 72: 1600-1609
        • Perazzolo Marra M.
        • Basso C.
        • De Lazzari M.
        • et al.
        Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse.
        Circ Cardiovasc Imaging. 2016; 9e005030
        • Aabel E.W.
        • Chivulescu M.
        • Lie O.H.
        • et al.
        Ventricular arrhythmias in arrhythmic mitral valve syndrome-a prospective continuous long-term cardiac monitoring study.
        Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2023; 25: 506-516
      4. Benjamin Essayagh M, * Avi Sabbag, MD,* Clémence Antoine, MD, Giovanni Benfari, MD, Li-Tan Yang, MD, Joseph Maalouf, MD, Samuel Asirvatham, MD, Hector Michelena, MD, Maurice Enriquez-Sarano, MD. Presentation and Outcome of Arrhythmic Mitral Valve Prolapse. J Am Coll Cardiol 2020;76:637-649.

        • Muthukumar L.
        • Rahman F.
        • Jan M.F.
        • et al.
        The Pickelhaube Sign: Novel Echocardiographic Risk Marker for Malignant Mitral Valve Prolapse Syndrome.
        JACC Cardiovasc Imaging. 2017; 10: 1078-1080
        • Chahal N.S.
        • Lim T.K.
        • Jain P.
        • Chambers J.C.
        • Kooner J.S.
        • Senior R.
        Normative reference values for the tissue Doppler imaging parameters of left ventricular function: a population-based study.
        Eur J Echocardiogr. 2010; 11: 51-56
        • Enriquez-Sarano M.
        • Avierinos J.F.
        • Messika-Zeitoun D.
        • et al.
        Quantitative determinants of the outcome of asymptomatic mitral regurgitation.
        N Engl J Med. 2005; 352: 875-883
        • van Wijngaarden S.E.
        • Abou R.
        • Hiemstra Y.L.
        • Ajmone Marsan N.
        • Bax J.J.
        • Delgado V.
        Regional Left Ventricular Myocardial Mechanics in Degenerative Myxomatous Mitral Valve Disease: A Comparison Between Fibroelastic Deficiency and Barlow's Disease.
        JACC Cardiovasc Imaging. 2018; 11: 1362-1364
        • Wilde A.A.
        • Duren D.R.
        • Hauer R.N.
        • et al.
        Mitral valve prolapse and ventricular arrhythmias: observations in a patient with a 20-year history.
        J Cardiovasc Electrophysiol. 1997; 8: 307-316
        • Singh S.N.
        • Fletcher R.D.
        • Fisher S.G.
        • et al.
        Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
        N Engl J Med. 1995; 333: 77-82
        • Zhong L.
        • Lee Y.H.
        • Huang X.M.
        • et al.
        Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study.
        Heart rhythm : the official journal of the Heart Rhythm Society. 2014; 11: 187-193
        • Ruskin J.N.
        The cardiac arrhythmia suppression trial (CAST).
        N Engl J Med. 1989; 321: 386-388
        • Hyman M.C.
        • Mustin D.
        • Supple G.
        • et al.
        Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy.
        Heart rhythm : the official journal of the Heart Rhythm Society. 2018; 15: 159-163
        • Ling Z.
        • Liu Z.
        • Su L.
        • et al.
        Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study.
        Circulation. Arrhythmia and electrophysiology. 2014; 7: 237-243
        • Lamba J.
        • Redfearn D.P.
        • Michael K.A.
        • Simpson C.S.
        • Abdollah H.
        • Baranchuk A.
        Radiofrequency catheter ablation for the treatment of idiopathic premature ventricular contractions originating from the right ventricular outflow tract: a systematic review and meta-analysis.
        Pacing Clin Electrophysiol. 2014; 37: 73-78
        • Enriquez A.
        • Shirai Y.
        • Huang J.
        • et al.
        Papillary muscle ventricular arrhythmias in patients with arrhythmic mitral valve prolapse: Electrophysiologic substrate and catheter ablation outcomes.
        J Cardiovasc Electrophysiol. 2019; 30: 827-835
        • Lee A.
        • Hamilton-Craig C.
        • Denman R.
        • Haqqani H.M.
        Catheter ablation of papillary muscle arrhythmias: Implications of mitral valve prolapse and systolic dysfunction.
        Pacing Clin Electrophysiol. 2018; 41: 750-758
        • Peichl P.
        • Baran J.
        • Wichterle D.
        • et al.
        The tip of the muscle is a dominant location of ventricular ectopy originating from papillary muscles in the left ventricle.
        J Cardiovasc Electrophysiol. 2018; 29: 64-70
        • Syed F.F.
        • Ackerman M.J.
        • McLeod C.J.
        • et al.
        Sites of Successful Ventricular Fibrillation Ablation in Bileaflet Mitral Valve Prolapse Syndrome.
        Circulation. Arrhythmia and electrophysiology. 2016; 9
        • Ezzeddine F.M.
        • Siontis K.C.
        • Giudicessi J.
        • et al.
        Substrate Characterization and Outcomes of Catheter Ablation of Ventricular Arrhythmias in Patients With Mitral Annular Disjunction.
        Circulation. Arrhythmia and electrophysiology. 2022; 15e011088
        • Bumgarner J.M.
        • Patel D.
        • Kumar A.
        • et al.
        Management and outcomes in mitral valve prolapse with ventricular arrhythmias undergoing ablation and/or implantation of ICDs.
        Pacing Clin Electrophysiol. 2019; 42: 447-452
        • Ross A.
        • DeWeese J.A.
        • Yu P.N.
        Refractory ventricular arrhythmias in a patient with mitral valve prolapse. Successful control with mitral valve replacement.
        J Electrocardiol. 1978; 11: 289-295
        • Al-Bassam M.S.
        • Cooley D.A.
        Arrhythmia with Mitral Valve Prolapse: Results of Annuloplasty in Two Patients.
        Cardiovasc Dis. 1978; 5: 397-405
        • Pocock W.A.
        • Barlow J.B.
        • Marcus R.H.
        • Barlow C.W.
        Mitral valvuloplasty for life-threatening ventricular arrhythmias in mitral valve prolapse.
        Am Heart J. 1991; 121: 199-202
        • Beroukhim R.S.
        • Reed J.H.
        • Schaffer M.S.
        • Yetman A.T.
        Surgical correction of mitral valve prolapse : a cure for recurrent ventricular tachycardia in Marfan syndrome?.
        Pediatr Cardiol. 2006; 27: 755-758
        • Alqarawi W.
        • Birnie D.H.
        • Burwash I.G.
        Mitral valve repair results in suppression of ventricular arrhythmias and normalization of repolarization abnormalities in mitral valve prolapse.
        HeartRhythm Case Rep. 2018; 4: 191-194
        • Abbadi D.R.
        • Purbey R.
        • Poornima I.G.
        Mitral valve repair is an effective treatment for ventricular arrhythmias in mitral valve prolapse syndrome.
        Int J Cardiol. 2014; 177: e16-18
        • Hosseini S.
        • Rezaei Y.
        • Samiei N.
        • et al.
        Effects of mitral valve repair on ventricular arrhythmia in patients with mitral valve prolapse syndrome: A report of two cases.
        Int J Cardiol. 2016; 222: 603-605
        • Vaidya V.R.
        • DeSimone C.V.
        • Damle N.
        • et al.
        Reduction in malignant ventricular arrhythmia and appropriate shocks following surgical correction of bileaflet mitral valve prolapse.
        J Interv Card Electrophysiol. 2016; 46: 137-143
        • El-Eshmawi A.
        • Pandis D.
        • Miller M.A.
        • et al.
        Surgical Cryoablation of Papillary Muscle PVCs During Mitral Valve Surgery: Therapeutic Consideration for Malignant MVP.
        J Am Coll Cardiol. 2020; 76: 3061-3062
        • Naksuk N.
        • Syed F.F.
        • Krittanawong C.
        • et al.
        The effect of mitral valve surgery on ventricular arrhythmia in patients with bileaflet mitral valve prolapse.
        Indian Pacing Electrophysiol J. 2016; 16: 187-191
      5. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72-e227.

        • Vahanian A.
        • Beyersdorf F.
        • Praz F.
        • et al.
        2021 ESC/EACTS Guidelines for the management of valvular heart disease.
        European heart journal. 2022; 43: 561-632
        • Alqarawi W.
        • Dewidar O.
        • Tadros R.
        • et al.
        Defining idiopathic ventricular fibrillation: A systematic review of diagnostic testing yield in apparently unexplained cardiac arrest.
        Heart rhythm : the official journal of the Heart Rhythm Society. 2021; 18: 1178-1185